期刊文献+

莫西沙星所致心律失常文献概述 被引量:7

原文传递
导出
摘要 莫西沙星为第四代喹诺酮类药物,临床常用于敏感菌所致的呼吸道感染。近年来国内有文献报道,本品可致心律失常,现概述如下:杜志强报道,患男,72岁,因右肺感染给予莫西沙星400mg静滴,qd,用药后出现意识模糊,胸闷、气短,复查心电图示Q-T间期延长,停药后改用头孢哌酮舒巴坦治疗,未再出现上述状况。卢丽华等报道,患男,49岁,因肺部感染给予莫西沙星400mg口服,45分钟后感到全身皮肤不适,继而出现心慌、心悸,心率120次/分钟,停药后经对症处理后缓解。
出处 《中国药物滥用防治杂志》 CAS 2015年第2期115-115,110,共2页 Chinese Journal of Drug Abuse Prevention and Treatment
  • 相关文献

参考文献8

二级参考文献18

  • 1谈艳,张少平,陈银娣.抗抑郁药和抗精神病药物所致QT间期延长和尖端扭转型室速[J].中国神经精神疾病杂志,2004,30(5). 被引量:12
  • 2Adams M, Tavakoli H. Gatifloxacin-induced hallucinations in a 19- year-old man [ J ]. Psychosomatics,2006,47 (4) :360
  • 3郭艺芳 马博聪译.AHA/ACCF颁布院内预防TdP科学声明.中国医学论坛报,2010,36(6):2-2.
  • 4Malik M, Hnatkova K, Schmidt A, et al. Electrocardiographic QTc changes due to moxifloxacin infusion[J]. J Clin Pharmacol, 2009, 49(6):674-683.
  • 5Tran H, White CM, Chow MSS, et al. An evaluation of the impact of gender and age on QT dispersion in healthy subjects[J]. Ann Noninv Electrocardiol, 2001, 6(2): 129-133.
  • 6Kluger J, Giedrimiene D, White CM, et al. A comparison of the QT and QTc dispersion among patients with sustained ventricular tachyarrhythmias and different etiologies of heart disease[J]. Ann Noninv Electrocardiol, 2001, 6(4):319-322.
  • 7Sherazi S, DiSalle M, Daubert JP, et al. Moxifloxacin-induced torsades de pointes[J]. Cardiol J, 2008, 15(1):71-73.
  • 8陈灏珠.一起由酸败油脂引起的食物中毒[J].实用内科学[M]第11版[M].北京:人民卫生出版社,2001.917-919.
  • 9张相彩,徐颖颖,吕小琴.莫西沙星的不良反应[J].中国临床药学杂志,2007,16(5):326-327. 被引量:9
  • 10田春华,杨景勋.莫西沙星引起心动过速首例报告[J]中国新药杂志,2001(04).

共引文献43

同被引文献46

  • 1于培明,黄泰康.不良反应概念的合理界定[J].中国药房,2007,18(5):392-393. 被引量:29
  • 2阚周密,刘阳,冯婉玉,贾大林,曾定尹.血清地高辛浓度与地高辛中毒临床相关因素分析[J].山东医药,2007,47(17):49-50. 被引量:7
  • 3Sanjith S, Raodeo A, Clerk A, et al. Moxifloxacin-induced rhabdomyolysis[J]. Intensive Care Med, 2012, 38(4): 725.
  • 4Hut J, Liu Z, Tong W, et al. Drug-induced rhabdomyolysis: from systems pharmacology analysis to biochemical flux[J]. Chem Res Toxicol, 2014, 27(3): 421-432.
  • 5Hohenegger M. Drug induced rhabdomyolysis[J]. Curr Opin Pharmacol, 2012, 12(3): 335-339.
  • 6Tintinalli JE, Kelen GD, Stapczynski JS. Emergency medicine: a comprehensive study guide[M]. 6th ed. New York: McGraw-Hill Inc, 2004.
  • 7L9pez JR, Rojas B, Gonzalez MA, et al. Myoplasmic Ca2+ concentration during exertional rhabdomyolysis[J]. Lancet, 1995, 345(8947): 424-425.
  • 8Duarte JA, Soares JM, Appell HJ. Nifedipine diminishes exercise- induced muscle damage in mouse[J]. Int J Sports Med, 1992, 13(3): 274-277.
  • 9Ginz HF, Levano S, Girard T, et al. Dantrolene for severe rhabdomyolysis in Staphylococcus aureus toxic shock syndrome[J]. Eur J Anaesthesiol, 2012, 29(3): 161-162.
  • 10Vilar S, Harpaz R, Chase HS, et al. Facilitating adverse drug event detection in pharmaeovigilance databases using molecular structure similarity: application to rhabdomyolysis[J]. J Am Med Inform Assoc, 2011, 18(Suppl 1): i73-i80.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部